PDX INSIGHTS
PIONEERING CANCER RESEARCH
Home
Collections
Bladder
Breast
Leukemia
Liver
Pancreas
Sarcoma
Omics Tools
Management
Data Management
File Management
Publications
Contact Us
Log In
You need to enable JavaScript to run this app page.
Liver
TCH-HB05
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: TCH-HB05
Contact Model Developer
Model Contact
Model: TCH-HB05
Model Contact: Sarah Woodfield
Institution: TCH Liver PDX Program
Email:
sewoodfi@texaschildrens.org
Patient Information
Clinical Timeline
Color Keys:
Unknown
None
Low
Moderate
High
Very High
Clinical Information at Collection
Pathology Information at Collection
Model Information for Model: TCH-HB05
Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Mutations (Cancer Gene Census List)
Mutation data is currently not available.
CNV
There are no omics data for this model.
Histology Information for Model: TCH-HB05
There are no histology images for this model.
Metastasis Information for Model: TCH-HB05
Patient
PDX
Lung
Patient Treatment Information for Model: TCH-HB05
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
15
Cisplatin, 5-Fluorouracil/Vincristine
Neoadjuvant
2.33
2.37
15 days
Partial Response
Partial Response
25
Cisplatin, 5-Fluorouracil/Vincristine
Adjuvant
2.42
2.54
44 days
Partial Response
Partial Response
AFP 471
35
Off Therapy Follow-up
Adjuvant
2.6
2.7
37 days
Partial Response
AFP 47.5
Please wait...
